Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4

M. Masetti, G. Acquaviva, M. Visani, G. Tallini, A. Fornelli, M. Ragazzi, F. Vasuri, D. Grifoni, S. Di Giacomo, S. Fiorino, R. Lombardi, D. Tuminati, M. Ravaioli, C. Fabbri, M.L. Bacchi-Reggiani, A. Pession, E. Jovine, D. de Biase

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)323-334
Number of pages12
JournalCancer Biomarkers
Volume21
Issue number2
DOIs
Publication statusPublished - Jan 2 2018

Cite this

Masetti, M., Acquaviva, G., Visani, M., Tallini, G., Fornelli, A., Ragazzi, M., Vasuri, F., Grifoni, D., Di Giacomo, S., Fiorino, S., Lombardi, R., Tuminati, D., Ravaioli, M., Fabbri, C., Bacchi-Reggiani, M. L., Pession, A., Jovine, E., & de Biase, D. (2018). Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer Biomarkers, 21(2), 323-334. https://doi.org/10.3233/CBM-170464